Contact this trialFirst, we need to learn more about you.
NDI-034858 for Psoriatic Arthritis
Recruiting0 awardsPhase 2
Atlanta, Georgia
This trial will test a new drug, NDI-034858, for treating psoriatic arthritis. The goal is to see if it is effective, safe, and well tolerated.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.